We are pleased to announce that a study demonstrating the clinical utility of the PromarkerD test...
Proteomics Commences Therapeutic Drug Discovery Program
The Company is pleased to announce that it has commenced a Therapeutic Drug Discovery program utilising its proprietary proteomics-based technology platform.